On March 22, 2024, OliX Pharmaceuticals, Inc closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14,430 KRW | +1.19% | -4.94% | -1.03% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
37,500 KRW | -1.32% | -3.35% | 2.48B | ||
14,430 KRW | +1.19% | -4.94% | 173M | ||
12,250 KRW | -1.84% | -5.04% | 3.14B | ||
7,450 KRW | -1.84% | -6.99% | 2.9B | ||
1st Jan change | Capi. | |
---|---|---|
-1.03% | 173M | |
+12.04% | 116B | |
+13.23% | 106B | |
-10.01% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-14.14% | 16.33B | |
+6.38% | 14.14B | |
+29.89% | 12.02B |
- Stock Market
- Equities
- A226950 Stock
- News OliX Pharmaceuticals, Inc
- OliX Pharmaceuticals, Inc announced that it has received KRW 14.7 billion in funding from a group of investors